Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Jacobsen

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Diabetes Care|January 19, 2022
Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY StudyLaura M Jacobsen, Kendra Vehik, Riitta Veijola, et al.
Diabetes|February 26, 2021
Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up ReportAndrea Lin, Jasmine A Mack, Brittany Bruggeman, et al.
Diabetes Care|September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to PreventionEmily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adultsErin L Templeman, Nick Thomas, Susan Martin, et al.
Diabetes|August 28, 2025
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time IntervalEmily K Sims, William E Russell, David Cuthbertson, et al.
Diabetes Care|May 6, 2026
Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive AdultsErin L Templeman, Nick Thomas, Susan Martin, et al.
JCI Insight|July 11, 2023
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetesLaura M Jacobsen, Kirsten Diggins, Lori Blanchfield, et al.
Pediatric Diabetes|January 11, 2019
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY childrenLaura M Jacobsen, Helena E Larsson, Roy N Tamura, et al.
Diabetes|December 10, 2025
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and ProgressionTaylor M Triolo, Jay M Sosenko, David Cuthbertson, et al.
Educational Technology Research and Development : ETR & D|October 24, 2022
Learning experience design of an mHealth self-management intervention for adolescents with type 1 diabetesMatthew Schmidt, Jie Lu, Wenjing Luo, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Diabetes Care|January 19, 2022
Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY StudyLaura M Jacobsen, Kendra Vehik, Riitta Veijola, et al.
Diabetes|February 26, 2021
Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up ReportAndrea Lin, Jasmine A Mack, Brittany Bruggeman, et al.
Diabetes Care|September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to PreventionEmily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adultsErin L Templeman, Nick Thomas, Susan Martin, et al.
Diabetes|August 28, 2025
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time IntervalEmily K Sims, William E Russell, David Cuthbertson, et al.
Diabetes Care|May 6, 2026
Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive AdultsErin L Templeman, Nick Thomas, Susan Martin, et al.
JCI Insight|July 11, 2023
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetesLaura M Jacobsen, Kirsten Diggins, Lori Blanchfield, et al.
Pediatric Diabetes|January 11, 2019
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY childrenLaura M Jacobsen, Helena E Larsson, Roy N Tamura, et al.
Diabetes|December 10, 2025
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and ProgressionTaylor M Triolo, Jay M Sosenko, David Cuthbertson, et al.
Educational Technology Research and Development : ETR & D|October 24, 2022
Learning experience design of an mHealth self-management intervention for adolescents with type 1 diabetesMatthew Schmidt, Jie Lu, Wenjing Luo, et al.
Pageof 8